These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 10967804)

  • 21. Prevalence of genotypic resistance among antiretroviral drug-naive HIV-1-infected patients in Belgium.
    Van Vaerenbergh K; Debaisieux L; De Cabooter N; Declercq C; Desmet K; Fransen K; Maes B; Marissens D; Miller K; Muyldermans G; Sprecher S; Stuyver L; Vaira D; Verhofstede C; Zissis G; Van Ranst M; De Clercq E; Desmyter J; Vandamme AM
    Antivir Ther; 2001 Mar; 6(1):63-70. PubMed ID: 11417763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [No comparison with NRTI. Tenofovir is robust against resistance trouble].
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():65. PubMed ID: 12043079
    [No Abstract]   [Full Text] [Related]  

  • 23. Resistance profiles to antiretroviral drugs in HIV-1 drug-naive patients in Argentina.
    Kijak GH; Pampuro SE; Avila MM; Zala C; Cahn P; Wainberg MA; Salomón H
    Antivir Ther; 2001 Mar; 6(1):71-7. PubMed ID: 11417764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Faculty demands AIDS drugs for all.
    Novak K
    Nat Med; 2002 Jan; 8(1):6-7. PubMed ID: 11786883
    [No Abstract]   [Full Text] [Related]  

  • 25. Next steps against AIDS.
    Nature; 2001 Apr; 410(6832):1009. PubMed ID: 11323620
    [No Abstract]   [Full Text] [Related]  

  • 26. Therapies. Confronting the limits of success.
    Cohen J
    Science; 2002 Jun; 296(5577):2320-4. PubMed ID: 12089422
    [No Abstract]   [Full Text] [Related]  

  • 27. [Current trends and research emphasis. Epidemiology, resistance testing, vaccination strategies].
    Oette M; Kroidl A; Göbels K; Heintges T; Wettstein M; Häussinger D; Hamouda O; Kaiser R; Beerenwinkel N
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():73-6. PubMed ID: 12043081
    [No Abstract]   [Full Text] [Related]  

  • 28. HIV drug program likely to miss 2005 target.
    Nat Med; 2005 Mar; 11(3):241. PubMed ID: 15746927
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug-resistant reverse transcriptase genotyping and phenotyping of B and non-B subtypes (F and A) of human immunodeficiency virus type I found in Brazilian patients failing HAART.
    Caride E; Brindeiro R; Hertogs K; Larder B; Dehertogh P; Machado E; de Sá CA; Eyer-Silva WA; Sion FS; Passioni LF; Menezes JA; Calazans AR; Tanuri A
    Virology; 2000 Sep; 275(1):107-15. PubMed ID: 11017792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. University shuts down virologist's work on questionable AIDS drug.
    Bolognesi N
    Nat Med; 2006 Sep; 12(9):982. PubMed ID: 16960558
    [No Abstract]   [Full Text] [Related]  

  • 31. South Africa breaks through to realism on antiretrovirals for AIDS.
    Cullinan K
    Bull World Health Organ; 2002; 80(6):521-2. PubMed ID: 12132019
    [No Abstract]   [Full Text] [Related]  

  • 32. HIV drug development: the next 25 years.
    Flexner C
    Nat Rev Drug Discov; 2007 Dec; 6(12):959-66. PubMed ID: 17932493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Common HIV drug-drug interactions.
    O'Brien LW
    AIDS Read; 1999; 9(2):104-9. PubMed ID: 12728892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Care for HIV/AIDS during parturition].
    Veser T
    Krankenpfl Soins Infirm; 2009; 102(9):24-5. PubMed ID: 19771823
    [No Abstract]   [Full Text] [Related]  

  • 35. Circulating HIV type 1 drug resistance will have limited impact on the effectiveness of preexposure prophylaxis among young women in Zimbabwe.
    van de Vijver DA; Derdelinckx I; Boucher CA
    J Infect Dis; 2009 May; 199(9):1310-7. PubMed ID: 19301982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Choice of the initial treatment in HIV1 infected patients].
    Poizot Martin I
    Med Mal Infect; 2007 Nov; 37(11):767-72. PubMed ID: 17977682
    [No Abstract]   [Full Text] [Related]  

  • 37. Emerging manifestations of HIV/AIDS: is it the virus or the antiviral therapy?
    Laurence J
    AIDS Read; 2001 Feb; 11(2):64-5. PubMed ID: 11279873
    [No Abstract]   [Full Text] [Related]  

  • 38. Tennessee's HIV Drug Assistance Program (HDAP).
    Vineyard D
    Tenn Med; 2003 Oct; 96(10):475. PubMed ID: 14574725
    [No Abstract]   [Full Text] [Related]  

  • 39. Success hinges on support for treatment.
    Hale P; Makgoba MW; Merson MH; Quinn TC; Richman DD; Vella S; Wabwire-Mangen F; Wain-Hobson S; Weiss RA
    Nature; 2001 Jul; 412(6844):272. PubMed ID: 11460135
    [No Abstract]   [Full Text] [Related]  

  • 40. Spectacular failure--a view from the epicenter.
    Crewe M
    Yale J Health Policy Law Ethics; 2004; 4(1):157-63. PubMed ID: 15052866
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.